News Sentiment

600276 sentiment intelligence

Jiangsu Hengrui Pharmaceuticals Co.,Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 53 Balanced news tone 22 relevant articles
Exchange SHH China
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 53.19 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 22

directly relevant articles

Source quality 6

high-authority source matches

Trend context Trend inactive

-4.6% over one week, +9.9% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Jiangsu Hengrui Pharmaceuticals' Contrast Agent Added to China's Essential Medicines List

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction -4.6% Price reacting lower
Trend fit Trend inactive 9.9% over four weeks
Fair value 6.7% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 18
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 22
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
South China Morning Post 4
Reuters 3
Bloomberg.com 3
Moomoo 2
Ad-hoc-news.de 2
BioWorld News 2
TradingView 1
Endpoints News 1

Event Lens

What the news is about

Classified themes
Market update 12
Deals and strategy 8
Earnings 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-22 of 22